PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 4, 20260 citationsOpen Access

Pilomatricoma: A Case Series Highlighting Cytological Diagnostic Pitfalls

VTVishal TayadePMPallavi MehraRBRicha Bhartiya

Key Points

  • The aim is to explore the diagnostic challenges of pilomatricoma in fine-needle aspiration cytology.
  • Reviewed six histologically confirmed cases of pilomatricoma.
  • Analyzed cytological diagnoses compared to histopathological outcomes.
  • Assessed the role of sampling techniques in diagnostic accuracy.
  • Correct cytological diagnosis achieved in four out of six cases (66.7%).
  • Two cases misdiagnosed as metastatic adenocarcinoma and small round cell tumor.
  • All cases confirmed as pilomatricoma through histopathology with no complications.

Abstract

Pilomatricoma (PMX) is an uncommon benign skin adnexal tumor that frequently poses diagnostic challenges on fine-needle aspiration cytology (FNAC) due to its variable morphological spectrum. We present six histologically confirmed cases of PMX from our institution, emphasizing the cytological diagnostic pitfalls. The series included three females and three males (age range: 28-52 years) presenting with subcutaneous nodules at various locations. Clinical diagnoses include lipoma, sebaceous cyst, and tuberculosis. Correct cytological diagnosis was achieved in four cases (66.7%), while two cases were misdiagnosed as metastatic adenocarcinoma and small round cell tumor due to focal sampling and predominance of basaloid cells. All cases were confirmed as PMX on histopathology with uneventful follow-up. This series highlights the importance of recognizing the dual cell population (ghost cells and basaloid cells), performing multiple needle passes from different sites, and awareness of cytological mimickers to avoid misdiagnosis. PMX should always be considered in the differential diagnosis when primitive-appearing cells are aspirated from subcutaneous nodules, particularly to prevent unnecessary aggressive workup for malignancy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tayade et al. (2026) studied this question.

synapsesocial.com/papers/69a7ccd5d48f933b5eed89a7https://doi.org/10.21276/apalm.3764
Ask AI
Helpful
Bookmark
Share
View Full Paper